Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Lane

Showing results (171-180 of 265) with videos related to

Pageof 27
Sort By:
The Journal of Biological Chemistry|October 25, 1985
Characterization of peptides cleaved by plasmin from the C-terminal polymerization domain of human fibrinogenC Southan, E Thompson, M Panico, et al.
Clinical Nephrology|January 1, 1991
Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulationH A Ireland, M D Boisclair, D A Lane, et al.
The Journal of Biological Chemistry|December 5, 1987
Structural requirements for the neutralization of heparin-like saccharides by complement S protein/vitronectinD A Lane, A M Flynn, G Pejler, et al.
Thrombosis and Haemostasis|February 28, 1977
Intermittent plasminogen-streptokinase treatment of deep vein thrombosisM F Scully, D A Lane, S Sagar, et al.
Journal of Clinical Pathology|June 1, 1988
Acquired dysfibrinogenaemia masquerading as disseminated intravascular coagulation in acute pancreatitisJ T Wilde, W E Thomas, D A Lane, et al.
British Journal of Haematology|April 1, 1987
Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparinD A Lane, A Flynn, H Ireland, et al.
British Journal of Haematology|May 1, 1996
Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V LeidenC Rintelen, C Mannhalter, H Ireland, et al.
Thrombosis and Haemostasis|April 1, 1997
Decrease in factor VII coagulant activity during percutaneous transluminal coronary angioplasty by heparin-mediated lipolytic actionM Mukherjee, M F Scully, V V Kakkar, et al.
Thrombosis and Haemostasis|November 1, 2001
Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolismS Kuhle, D A Lane, K Jochmanns, et al.
Environmental Science & Technology|December 27, 2011
Development and evaluation of a novel gas and particle sampler for semivolatile chlorinated organic compounds in ambient airD A Lane, N D Johnson, S C Barton, et al.
Pageof 27

Showing results (171-180 of 265) with videos related to

Sort By:
Pageof 27
The Journal of Biological Chemistry|October 25, 1985
Characterization of peptides cleaved by plasmin from the C-terminal polymerization domain of human fibrinogenC Southan, E Thompson, M Panico, et al.
Clinical Nephrology|January 1, 1991
Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulationH A Ireland, M D Boisclair, D A Lane, et al.
The Journal of Biological Chemistry|December 5, 1987
Structural requirements for the neutralization of heparin-like saccharides by complement S protein/vitronectinD A Lane, A M Flynn, G Pejler, et al.
Thrombosis and Haemostasis|February 28, 1977
Intermittent plasminogen-streptokinase treatment of deep vein thrombosisM F Scully, D A Lane, S Sagar, et al.
Journal of Clinical Pathology|June 1, 1988
Acquired dysfibrinogenaemia masquerading as disseminated intravascular coagulation in acute pancreatitisJ T Wilde, W E Thomas, D A Lane, et al.
British Journal of Haematology|April 1, 1987
Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparinD A Lane, A Flynn, H Ireland, et al.
British Journal of Haematology|May 1, 1996
Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V LeidenC Rintelen, C Mannhalter, H Ireland, et al.
Thrombosis and Haemostasis|April 1, 1997
Decrease in factor VII coagulant activity during percutaneous transluminal coronary angioplasty by heparin-mediated lipolytic actionM Mukherjee, M F Scully, V V Kakkar, et al.
Thrombosis and Haemostasis|November 1, 2001
Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolismS Kuhle, D A Lane, K Jochmanns, et al.
Environmental Science & Technology|December 27, 2011
Development and evaluation of a novel gas and particle sampler for semivolatile chlorinated organic compounds in ambient airD A Lane, N D Johnson, S C Barton, et al.
Pageof 27